26-003578 maxcyte expert GTX electroporation device and installation/operational qualification (IQ/OQ)
Ended Purchase Order Awarded
- Contract number
- 75N98026P00164
- Awardee
-
Maxcyte, Inc. UEI KM8DZV21HFM8
- Awarding agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Obligated
- $126,250
Award facts
- Opportunity
-
- MaxCyte ExPERT GTx Electroporation Device and Installation/Operational Qualification (IQ/OQ) Pre-Solicitation · 26003578 · Posted Mar 6, 2026
- Contract value 100% obligated
- $126,250.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
The National Institutes of Health Clinical Center, within the Department of Health and Human Services, awarded a $126.3K firm fixed-price purchase order to Maxcyte, Inc. for the procurement and installation of a MaxCyte ExPERT GTx Electroporation Device along with Installation Qualification and Operational Qualification (IQ/OQ) services. The contract, awarded on March 24, 2026, with completion targeted for April 23, 2026, will be performed at the NIH Clinical Center in Bethesda, Maryland. This procurement was conducted on a sole-source basis with no small business set-aside designation. The equipment will support the Center for Cellular Engineering's development and manufacturing of cell-based therapies, which operate under FDA Current Good Manufacturing Practices regulations. The acquisition addresses an operational necessity, as the facility's existing MaxCyte Gen2 GT electroporation system will no longer receive manufacturer support beginning in mid-2026, requiring transition to the newer ExPERT GTx platform to maintain continuity of clinical manufacturing protocols.
Maxcyte, Inc., a Rockville, Maryland-based biotechnology equipment manufacturer registered in SAM.gov since 2005, serves as the prime contractor and sole supplier for this award. The company specializes in advanced cell engineering technologies and electroporation systems for biomedical research and therapeutic manufacturing applications. This contract aligns with Maxcyte's established relationship with federal research institutions, including prior awards from the National Heart Lung and Blood Institute, National Institute of Allergy and Infectious Diseases, Veterans Health Administration, and the NIH Clinical Center. The funding source is the Office of Logistics and Acquisition Operations, a civilian agency within the Department of Health and Human Services.
Quick answers
Who was awarded contract 75N98026P00164?
75N98026P00164 was awarded to Maxcyte, Inc. by Office of Logisitics and Acquisition Operations (National Institutes of Health) on March 24, 2026.
How much is contract 75N98026P00164 worth?
The government has obligated $126,250 on 75N98026P00164.
Was contract 75N98026P00164 competed?
The extent of competition for 75N98026P00164 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award